.jpg)
Recent from talks
Krembil Research Institute
Knowledge base stats:
Talk channels stats:
Members stats:
Krembil Research Institute
The Krembil Research Institute, formerly known as the Toronto Western Research Institute, is an academic medical research institute in Toronto. It is one of the largest research institutes in Canada focusing on human neurological disease.
Krembil is one of the principal research institutes of the University Health Network and is the research institute of the Toronto Western Hospital.
Krembil researches treatments for Alzheimer's disease, Parkinson's disease, epilepsy, stroke, brain tumours, concussions, spinal cord injuries, neuro-ophthalmologic and other ocular disorders, multiple sclerosis and autoimmune disorders.
In the early 1980s, Toronto Western took on additional neurological and neurosurgical care responsibilities for the UHN group. In 1980, the Playfair Neuroscience Institute was created. In 1999, it was renamed the Toronto Western Research Institute. The Institute added research areas in ophthalmology, rheumatology and orthopaedics. By 2004, under the founding leadership of neurosurgeon C. Wallace, the Krembil had emerged as one of the largest research institutes in Canada with a neuroscience emphasis.
On November 13, 2015, the Krembil took on its current name from the Krembil family. In 2013, the Krembil Discovery Tower opened at Toronto Western.
Krembil neuroscientists explore the function of the nervous system as they develop treatments for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, epilepsy, spinal cord injuries, cerebral ischemia (stroke), vascular brain malformations, aneurysms, brain tumours and pain disorders.
The Krembil is also home to the Vision Science Research Program, a joint UHN/University of Toronto Program. This research is directed into the following areas: molecular genetics of blinding eye diseases with brain disorders; treatment and biophysics of glaucoma; eye movement control mechanisms; neuronal damage; retinal degeneration and diabetic retinopathy.
Arthritis and associated rheumatological degenerative diseases are the focus of the researchers in the musculoskeletal research program at the Krembil as part of the UHN Arthritis and Autoimmunity Research Centre. Their investigations are aimed at revealing the causes of, and generating therapies for, these autoimmune and orthopaedic ailments.[citation needed]
Hub AI
Krembil Research Institute AI simulator
(@Krembil Research Institute_simulator)
Krembil Research Institute
The Krembil Research Institute, formerly known as the Toronto Western Research Institute, is an academic medical research institute in Toronto. It is one of the largest research institutes in Canada focusing on human neurological disease.
Krembil is one of the principal research institutes of the University Health Network and is the research institute of the Toronto Western Hospital.
Krembil researches treatments for Alzheimer's disease, Parkinson's disease, epilepsy, stroke, brain tumours, concussions, spinal cord injuries, neuro-ophthalmologic and other ocular disorders, multiple sclerosis and autoimmune disorders.
In the early 1980s, Toronto Western took on additional neurological and neurosurgical care responsibilities for the UHN group. In 1980, the Playfair Neuroscience Institute was created. In 1999, it was renamed the Toronto Western Research Institute. The Institute added research areas in ophthalmology, rheumatology and orthopaedics. By 2004, under the founding leadership of neurosurgeon C. Wallace, the Krembil had emerged as one of the largest research institutes in Canada with a neuroscience emphasis.
On November 13, 2015, the Krembil took on its current name from the Krembil family. In 2013, the Krembil Discovery Tower opened at Toronto Western.
Krembil neuroscientists explore the function of the nervous system as they develop treatments for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, epilepsy, spinal cord injuries, cerebral ischemia (stroke), vascular brain malformations, aneurysms, brain tumours and pain disorders.
The Krembil is also home to the Vision Science Research Program, a joint UHN/University of Toronto Program. This research is directed into the following areas: molecular genetics of blinding eye diseases with brain disorders; treatment and biophysics of glaucoma; eye movement control mechanisms; neuronal damage; retinal degeneration and diabetic retinopathy.
Arthritis and associated rheumatological degenerative diseases are the focus of the researchers in the musculoskeletal research program at the Krembil as part of the UHN Arthritis and Autoimmunity Research Centre. Their investigations are aimed at revealing the causes of, and generating therapies for, these autoimmune and orthopaedic ailments.[citation needed]
Recent media